Table 1.
Demographic characteristics, comorbidities, and symptoms of the study population
| All patients (n = 286) | PCR positive (n = 157) | PCR negative (n = 129) | p | |
|---|---|---|---|---|
| Age (years) | 53.3 ± 17.9 | 51.8 ± 17.4 | 55.1 ± 18.5 | 0.119 |
| Gender (female) | 131 (45.8) | 76 (48.4) | 55 (42.6) | 0.584 |
| Smoking | 82 (28.7) | 47 (29.9) | 35 (27.1) | 0.679 |
| Comorbidities | ||||
| Hypertension | 129 (45.1) | 69 (43.9) | 60 (46.5) | 0.890 |
| Diabetes mellitus | 54 (18.9) | 27 (17.2) | 27 (20.9) | 0.450 |
| COPD/asthma | 33 (11.5) | 17 (10.8) | 16 (12.4) | 0.713 |
| Coronary artery disease | 32 (11.2) | 12 (7.6) | 20 (15.5) | 0.04 |
| Hyperlipidemia | 30 (10.5) | 16 (10.2) | 14 (10.9) | 0.849 |
| Atrial fibrilation | 12 (4.2) | 7 (4.5) | 5 (3.9) | 0.807 |
| Chronic renal failure | 10 (3.5) | 4 (2.5) | 6 (4.7) | 0.355 |
| Malignancy | 10 (3.5) | 6 (3.8) | 4 (3.1) | 0.741 |
| Symptoms | ||||
| Fever | 243 (85) | 137 (87.3) | 106 (82.2) | 0.248 |
| Cough | 185 (64.7) | 107 (68.2) | 78 (60.5) | 0.214 |
| Fatigue | 150 (52.4) | 88 (56.1) | 62 (48.1) | 0.192 |
| Dyspnea | 75 (26.2) | 40 (25.5) | 35 (27.1) | 0.788 |
| Myalgia | 51 (17.8) | 30 (19.1) | 21 (16.3) | 0.482 |
| Taste/smell abnormalities | 29 (10.1) | 22 (14) | 7 (5.4) | 0.018 |
| Anorexia | 28 (9.7) | 18 (11.5) | 10 (7.8) | 0.413 |
| Headache | 21 (7.3) | 11 (7) | 10 (7.8) | 0.889 |
| Pharyngalgia | 19 (6.6) | 10 (6.4) | 9 (6.9) | 0.851 |
| Diarrhea | 14 (4.9) | 8 (5.1) | 6 (4.7) | 0.862 |
| Nausea/vomiting | 12 (4.2) | 6 (3.8) | 6 (4.7) | 0.952 |
| Chest pain | 11 (3.8) | 6 (3.8) | 5 (3.9) | 0.901 |
| Palpitation | 9 (3.1) | 6 (3.8) | 3 (2.3) | 0.745 |
| Abdominal pain | 6 (2.3) | 2 (1.3) | 4 (3.1) | 0.813 |